Clinical Trial Update: Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Combivent to salbutamol in asthma patients with methacholine-induced bronchospasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Combivent (ipratropium bromide and albuterol)
• Salbutamol (salbutamol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 4 | Status: COMPLETED